Advertisement

U.S. Markets open in 3 hrs 16 mins

S&P Futures
3,934.75
+18.50(+0.47%)
Dow Futures
31,590.00
+103.00(+0.33%)
Nasdaq Futures
12,218.25
+77.75(+0.64%)
Russell 2000 Futures
1,770.90
+9.20(+0.52%)
Crude Oil
107.80
+0.18(+0.17%)
Gold
1,840.50
+10.20(+0.56%)

Advertisement

F-star Therapeutics, Inc. (FSTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

6.39

+0.03

(+0.47%)

At close: 04:00PM EDT

6.39

0.00

(0.00%)

Pre-Market:

05:22AM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Simply Wall St.
How Much Of F-star Therapeutics, Inc. (NASDAQ:FSTX) Do Institutions Own?
If you want to know who really controls F-star Therapeutics, Inc. ( NASDAQ:FSTX ), then you'll have to look at the...
- What Type Of Shareholders Make Up Scholastic Corporation's (NASDAQ:SCHL) Share Registry?
  Simply Wall St.
- What Type Of Shareholders Make Up Kingsoft Cloud Holdings Limited's (NASDAQ:KC) Share Registry?
  Simply Wall St.
GlobeNewswire
invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs
Proposed ~US$161 million all-cash acquisition to accelerate invoX’s strategy to build Sino Biopharm’s International Biopharmaceutical R&D Platform outside of China, transforming the lives of patients worldwideThe transaction demonstrates the strength of F-star’s differentiated bispecific antibody technology and provides backing from a top 40 global pharmaceutical company to accelerate growth and unlock potentialF-star’s unique next-generation tetravalent (2+2) bispecific antibody platform comple
Simply Wall St.
F-star Therapeutics, Inc. (NASDAQ:FSTX) Just Reported And Analysts Have Been Cutting Their Estimates
F-star Therapeutics, Inc. ( NASDAQ:FSTX ) just released its latest quarterly results and things are looking bullish...